The impact of autoimmunity-related early ovarian aging on ICSI cycle outcome

References

• Thomas R, Reid RL. Thyroid disease and reproductive dysfunction: a review. Obstet Gynecol. 1987;70:789–798.
   PubMed Web of Science ®Google Scholar
• Trokoudes KM, Skordis N, Picolos MK. Infertility and thyroid disorders. Curr Opin Obstet Gynecol. 2006;18:446–451.
   PubMed Web of Science ®Google Scholar
• Poppe K, Velkeniers B, Glinoer D. Thyroid disease and female reproduction. Clin Endocrinol. 2007;66:309–321.
   PubMed Web of Science ®Google Scholar
• Swain M, Swain T, Mohanty BK. Autoimmune thyroid disorders – an update. Indian J Clin Biochem. 2005;20:9–17.
   PubMedGoogle Scholar
• Kotani T. [Anti-TPO autoantibodies]. Rinsho Byori. 1998;46:324–330.
   PubMedGoogle Scholar
• Abalovich M, Mitelberg L, Allami C, et al. Subclinical hypothyroidism and thyroid autoimmunity in women with infertility. Gynecol Endocrinol. 2007;23:279–283.
   PubMed Web of Science ®Google Scholar
• Ghoraishian SM, Hekmati Moghaddam SH, Afkhami-Ardekani M. Relationship between anti-thyroid peroxidase antibody and thyroid function test. Iranian J Immunol. 2006;3:146–149.
   PubMedGoogle Scholar
• Unuane D, Poppe K. Female infertility: do we forget the thyroid? J Endocrinol Invest. 2015;38:571–574.
   PubMed Web of Science ®Google Scholar
• Revelli A, Casano S, Delle Piane L, et al. A retrospective study on IVF outcome in euthyroid patients with anti-thyroid antibodies: effects of levothyroxine, acetyl-salicylic acid and prednisolone adjuvant treatments. Reprod Biol Endocrinol. 2009;7:137.
   PubMed Web of Science ®Google Scholar
• Abbassi-Ghanavati M, Casey BM, Spong CY, et al. Pregnancy outcomes in women with thyroid peroxidase antibodies. Obstet Gynecol. 2010;116:381–386.
   PubMed Web of Science ®Google Scholar
• Bussen S, Steck T, Dietl J. Increased prevalence of thyroid antibodies in euthyroid women with a history of recurrent in vitro fertilization failure. Hum Reprod. 2000;15:545–548.
   PubMed Web of Science ®Google Scholar
• De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:2543–2565.
   PubMed Web of Science ®Google Scholar
• Benaglia L, Busnelli A, Somigliana E, et al. Incidence of elevation of serum thyroid-stimulating hormone during controlled ovarian hyperstimulation for in vitro fertilization. Eur J Obstet Gynecol Reprod Biol. 2014;173:53–57.
   PubMed Web of Science ®Google Scholar
• Busnelli A, Somigliana E, Benaglia L, et al. Thyroid axis dysregulation during in vitro fertilization in hypothyroid-treated patients. Thyroid. 2014;24:1650–1655.
   PubMed Web of Science ®Google Scholar
• Wood JW. Fecundity and natural fertility in humans. Oxf Rev Reprod Biol. 1989;11:61–109.
   PubMedGoogle Scholar
• te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002;8:141–154.
   PubMed Web of Science ®Google Scholar
• Rees M, Purdie D. Premature menopause. The handbook. In: Margaret R, David WP, editors. Management of the menopause. 4th ed. London (UK): Royal Society of Medicine Press Ltd.; 2006. p. 142–149.
   Google Scholar
• Novosad JA, Kalantaridou SN, Tong ZB, et al. Ovarian antibodies as detected by indirect immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation. BMC Womens Health. 2003;3:2.
   PubMedGoogle Scholar
• Hanoch J, Lavy Y, Holzer H, et al. Young low responders protected from untoward effects of reduced ovarian response. Fertil Steril. 1998;69:1001–1004.
   PubMed Web of Science ®Google Scholar
• Van Rooij IAJ, Bancsi LF, Brockmans FJ, et al. Women older than 40 years of age and those with elevated FSH levels differ in poor response rate and embryo quality in IVF. Fertil Steril. 2003;79:482–488.
   PubMed Web of Science ®Google Scholar
• Galey-Fontaine J, Cedrin-Durnerin I, Chaibi R, et al. Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders. Reprod Biomed Online. 2005;10:94–99.
   PubMed Web of Science ®Google Scholar
• De Sutter P, Dhont M. Poor response after hormonal stimulation for IVF is not related to ovarian aging. Fertil Steril. 2003;79:1294–1298.
   PubMed Web of Science ®Google Scholar
• Akande VA, Fleming CF, Hunt LP, et al. Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment. Hum Reprod. 2002;17:2003–2008.
   PubMed Web of Science ®Google Scholar
• El-Toukhy T, Khalaf Y, Hart R, et al. Young age does not protect against the adverse effects of reduced ovarian reserve – an eight year study. Hum Reprod. 2002;17:1519–1524.
   PubMed Web of Science ®Google Scholar
• Ebrahimi M, Akbari Asbagh F. The role of autoimmunity in premature ovarian failure. Iran J Reprod Med. 2015;13:461–472.
   PubMedGoogle Scholar
• Weghofer A, Brill H, Feichtinger R, et al. Does autoimmunity play a role in the pathophysiology of premature ovarian ageing? Reprod Biomed Online. 2008;16:830–834.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Wu L, Xu B, et al. A retrospective study on IVF/ICSI outcome in patients with anti-nuclear antibodies: the effects of prednisone plus low-dose aspirin adjuvant treatment. Reprod Biol Endocrinol. 2013;11:98.
   PubMed Web of Science ®Google Scholar
• Gleicher N, Weghofer A, Barad HD. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies. Fertil Steril. 2009;91:1707–1711.
   PubMed Web of Science ®Google Scholar
• Chernyshov VP, Radysh TV, Gura IV, et al. Immune disorders in women with premature ovarian failure in initial period. Am J Reprod Immunol. 2001;46:220–225.
   PubMed Web of Science ®Google Scholar
• Kwak-Kim J, Bao S, Lee SK, et al. Immunological modes of pregnancy loss: inflammation, immune effectors, and stress. Am J Reprod Immunol. 2014;72:129–140.
   PubMed Web of Science ®Google Scholar